65 related articles for article (PubMed ID: 15368578)
1. SMAF-1 inhibits the APC/beta-catenin pathway and shows properties similar to those of the tumor suppressor protein APC.
Karaguni IM; Gourzoulidou E; Carpintero M; Langerak A; Klein-Hitpass L; Möröy T; Winde G; Waldmann H; Müller O
Chembiochem; 2004 Sep; 5(9):1267-70. PubMed ID: 15368578
[No Abstract] [Full Text] [Related]
2. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
3. The Wnt/beta-catenin pathway regulates cardiac valve formation.
Hurlstone AF; Haramis AP; Wienholds E; Begthel H; Korving J; Van Eeden F; Cuppen E; Zivkovic D; Plasterk RH; Clevers H
Nature; 2003 Oct; 425(6958):633-7. PubMed ID: 14534590
[TBL] [Abstract][Full Text] [Related]
4. The APC tumor suppressor pathway.
Morin PJ; Weeraratna AT
Methods Mol Biol; 2003; 222():21-40. PubMed ID: 12710678
[No Abstract] [Full Text] [Related]
5. Fluorescence-based functional assay for Wnt/beta-catenin signaling activity.
Zhou L; An N; Jiang W; Haydon R; Cheng H; Zhou Q; Breyer B; Feng T; He TC
Biotechniques; 2002 Nov; 33(5):1126-8, 1130, 1132 passim. PubMed ID: 12449394
[TBL] [Abstract][Full Text] [Related]
6. RelA suppresses the Wnt/beta-catenin pathway without exerting trans-acting transcriptional ability.
Masui O; Ueda Y; Tsumura A; Koyanagi M; Hijikata M; Shimotohno K
Int J Mol Med; 2002 May; 9(5):489-93. PubMed ID: 11956654
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis.
Moldes M; Zuo Y; Morrison RF; Silva D; Park BH; Liu J; Farmer SR
Biochem J; 2003 Dec; 376(Pt 3):607-13. PubMed ID: 12954078
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
[TBL] [Abstract][Full Text] [Related]
9. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
Jung HC; Kim K
Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
[TBL] [Abstract][Full Text] [Related]
10. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
11. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
[TBL] [Abstract][Full Text] [Related]
12. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells.
Papkoff J; Aikawa M
Biochem Biophys Res Commun; 1998 Jun; 247(3):851-8. PubMed ID: 9647782
[TBL] [Abstract][Full Text] [Related]
13. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation.
Topol L; Jiang X; Choi H; Garrett-Beal L; Carolan PJ; Yang Y
J Cell Biol; 2003 Sep; 162(5):899-908. PubMed ID: 12952940
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Wnt signaling pathway by disabled-2 (Dab2).
Hocevar BA; Mou F; Rennolds JL; Morris SM; Cooper JA; Howe PH
EMBO J; 2003 Jun; 22(12):3084-94. PubMed ID: 12805222
[TBL] [Abstract][Full Text] [Related]
15. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
16. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
18. A protein knockdown strategy to study the function of beta-catenin in tumorigenesis.
Cong F; Zhang J; Pao W; Zhou P; Varmus H
BMC Mol Biol; 2003 Sep; 4():10. PubMed ID: 14516475
[TBL] [Abstract][Full Text] [Related]
19. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas.
Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M
Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
